Clinical Trial

Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the impact of implementing population-based genetics testing strategy for breast cancer precision prevention using the polygenic risk score and monogenic pathogenic variant (MPV) testing in the Norwegian healthcare setting.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-07; most recent amendment 2024-05-22.
Status change: Recruiting → Active, Not Recruiting 2024-05-22
Trial Details
NCT Number NCT05731453
Lead Sponsor Vestre Viken Hospital Trust
Collaborators: Oslo University Hospital
Conditions Breast Cancer
Enrollment 80 participants
Start Date 2023-02-01
Primary Completion 2024-05-01 (estimated)
Study Completion 2035-11-11 (estimated)
Updated on ClinicalTrials.gov 2024-05-23